However, our in vitro and in vivo data indicate that moderate overexpression of G6PD does not affect tumour onset in a WT background, nor in many other tumour-prone backgrounds (p53-null, Atm-null, MMTV-PyMT or Eμ-Myc). Here, TP53 is linked to neoplasm.